Abingdon Health PLC
LSE:ABDX
Abingdon Health PLC
LSE:ABDX
Price:
10.75 GBX
-2.27%
Market Closed
Updated:
May 20, 2024
Abingdon Health PLC
Operating Income
|
Abingdon Health PLC
Operating Income Peer Comparison
Comparables:
CTEC
TSTL
SPEC
AMS
RUA
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abingdon Health PLC
LSE:ABDX
|
Operating Income
-£3.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
ConvaTec Group PLC
LSE:CTEC
|
Operating Income
$2.5B
|
CAGR 3-Years
121%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
|
|
Tristel PLC
LSE:TSTL
|
Operating Income
£6.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
13%
|
|
|
Inspecs Group PLC
LSE:SPEC
|
Operating Income
£2.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Advanced Medical Solutions Group PLC
LSE:AMS
|
Operating Income
£18.9m
|
CAGR 3-Years
18%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
3%
|
|
|
Rua Life Sciences PLC
LSE:RUA
|
Operating Income
-£2.3m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
See Also
What is Abingdon Health PLC's Operating Income?
Operating Income
-3.6m
GBP
-3.6m
GBP
Based on the financial report for Jun 30, 2023, Abingdon Health PLC's Operating Income amounts to -3.6m GBP.
What is Abingdon Health PLC's Operating Income growth rate?
Operating Income CAGR 5Y
5%
5%
Over the last year, the Operating Income growth was 71%.
You don't have any saved screeners yet
